Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
103,309,752
-
Share change
-
+3,428,672
-
Total reported value
-
$2,646,654,588
-
Put/Call ratio
-
27%
-
Price per share
-
$25.62
-
Number of holders
-
81
-
Value change
-
+$101,543,635
-
Number of buys
-
53
-
Number of sells
-
33
Institutional Holders of CEREVEL THERAPEUTICS HLDNG I - COM (CERE) as of Q2 2021
As of 30 Jun 2021,
CEREVEL THERAPEUTICS HLDNG I - COM (CERE) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,309,752 shares.
The largest 10 holders included
Bain Capital Investors LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., ALKEON CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., Artal Group S.A., and FEDERATED HERMES, INC..
This page lists
81
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.